Posted by shellson2 on 21st of Jan 2025 at 11:28 am
VERU--could be a lottery ticket type play here.
Micro cap with news pending by 1/31. It's up nicely today on much
higher volume, breaking above July highs.
By 1/31/2025:
Enobosarm with semaglutide (Wegovy) - (QUALITY), Obesity
Phase 2b topline data due in January 2025. IND submitted to the
FDA, noted January 8, 2024. IND cleared February 6, 2024. Phase 2b
first patient dosed April 30, 2024. Phase 2b showed it was
well-tolerated across 1,027 patients, with an adverse event profile
comparable to placebo, noted June 24, 2024. Phase 2b full
enrollment reached August 8, 2024.
VERU--could be a lottery ticket
Posted by shellson2 on 21st of Jan 2025 at 11:28 am
VERU--could be a lottery ticket type play here. Micro cap with news pending by 1/31. It's up nicely today on much higher volume, breaking above July highs.
By 1/31/2025:
Enobosarm with semaglutide (Wegovy) - (QUALITY), Obesity
Phase 2b topline data due in January 2025. IND submitted to the FDA, noted January 8, 2024. IND cleared February 6, 2024. Phase 2b first patient dosed April 30, 2024. Phase 2b showed it was well-tolerated across 1,027 patients, with an adverse event profile comparable to placebo, noted June 24, 2024. Phase 2b full enrollment reached August 8, 2024.
Nice movement today in this
Posted by swamii2021 on 23rd of Jan 2025 at 12:30 pm
Nice movement today in this one. Took a small position, I appreciate the idea.
And news can come out
Posted by shellson2 on 23rd of Jan 2025 at 12:58 pm
And news can come out any day now, just reminder.
Thanks shellson2
Posted by steve on 23rd of Jan 2025 at 01:20 pm
Thanks shellson2
Shellson2 You are amazing
Posted by rbreese on 21st of Jan 2025 at 12:29 pm
Shellson2 You are amazing with all your research work.